Product Information
CABERGOLINE 0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.4462 per EA under NDC 00093542088. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093542088
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CABERGOLINEApproval Type
Generic (ANDA)
FDA Application
ANDA077750On Market Since
3/7/2007
Pharmacological Classes
Price Statistics
The NADAC for CABERGOLINE 0.5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 86.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4462 per EA |
|---|---|
| All-time high | $12.1817 (Apr 13, 2016) |
| All-time low | $1.0692 (Nov 20, 2024) |
| 52-week high | $1.6003 |
| 52-week low | $1.3567 |
| Median price | $2.6867 |
| Average price | $4.8152 |
| Largest weekly change | +45.5% (Nov 18, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CABERGOLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.4462 per EA (NDC 00093542088), effective Jun 24, 2026.
How has the price of CABERGOLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has declined 86.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?
Since Nov 28, 2013, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.0692 (Nov 20, 2024) to a high of $12.1817 (Apr 13, 2016), with a median of $2.6867 per EA.
Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CABERGOLINE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CABERGOLINE 0.5 MG TABLET?
CABERGOLINE 0.5 MG TABLET (NDC 00093542088) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification